AZD1222-induced mucosal immune responses are influenced by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection. Aksyuk et al.

Name: AZD1222-induced mucosal immune responses are influenced by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection. Aksyuk et al.
Creator: Anastasia Aksyuk
Published: 2022-12-06T17:43:53.185Z
Keywords: Vaccination, COVID-19

Aksyuk, Anastasia; Bansal, Himanshu; Wilkins, Deidre; Stanley, Ann Marie; Sproule, Stephanie; Maaske, Jill; Sanikommu, Satya; Hartman, William; Sobieszczyk, Magdalena; Falsey, Ann; Kelly, Elizabeth

doi:10.17632/3nxrpnf7m3.1

AZD1222-induced mucosal immune responses are influenced by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection. Aksyuk et al.

Published: 6 December 2022| Version 1 | DOI: 10.17632/3nxrpnf7m3.1

Contributors:

,

Description

Supplemental Table 3. Summary of GMTs, GMFRs, and seroresponse rates of anti-SARS-CoV-2 spike IgG and IgA as measured by MSD serology assay. Related to Figures 1–2.

Files

Funding

US Government

W15QKN-20-9-1003

Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority

W15QKN-21-9-1003

Infectious Diseases Clinical Research Consortium through the National Institute of Allergy and Infectious Diseases,

UM1 AI 148684, UM1 AI 148450, UM1 AI 148372, and UM1 AI 148574

AZD1222-induced mucosal immune responses are influenced by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection. Aksyuk et al.

Description

Files

Categories

Funding

Licence